NasalSpray | Financial Buzz

Healthcare Investing News Market News Technology The Market Buzz

FDA Grants Evoke Pharma with Market Exclusivity for GIMOTI®

David Kim04/26/2022

16903

Evoke Pharma, Inc. (NASDAQ: EVOK) has announced that the FDA has granted new drug product exclusivity for the company’s GIMOTI nasal spray. Evoke has been given exclusive marketing rights...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Altamira Therapeutics Provides Business Update on Bentrio Program

Andy Liao12/29/202106/22/2022

4288

Altamira Therapeutics Ltd. (NASDAQ: CYTO) has reported a business update on Bentrio. Bentrio is a nasal spray for protection against airborne viruses and allergens. The company has contracts with...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Pasithea Therapeutics Corp. (NASDAQ: KTTA) Surges Upon SPRAVATO Approval

financial buzz11/23/202106/13/2022

5803

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Pasithea Therapeutics Corp. Surges Upon SPRAVATO Approval” Pasithea Therapeutics Corp. (NASDAQ: KTTA) surged over 196% in premarket trading...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Impel NeuroPharma, Inc. (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment

financial buzz09/03/2021

1566

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Impel NeuroPharma, Inc Granted U.S. FDA Approval for its Acute Migraine Treatment” Impel NeuroPharma, Inc. (NASDAQ: IMPL)...

Biotechnology Healthcare Investing News Market News Personal Finance

FDA Clears Way for Generic Opioid Overdose Treatment

Austin Chiu01/22/2019

6500

3

The Food and Drug Administration is clearing the way for drug companies to increase access and lower the cost of a life-saving drug used to treat opioid overdoses. The...

Tag: NasalSpray

FDA Grants Evoke Pharma with Market Exclusivity for GIMOTI®

Altamira Therapeutics Provides Business Update on Bentrio Program

“The Buzz” Show: Pasithea Therapeutics Corp. (NASDAQ: KTTA) Surges Upon SPRAVATO Approval

“The Buzz” Show: Impel NeuroPharma, Inc. (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment

FDA Clears Way for Generic Opioid Overdose Treatment

ABOUT US

Tweets